After Golden Cross, Assertio (ASRT)’s Technical Outlook is Bright

Assertio Holdings, Inc. (ASRT) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, ASRT’s 50-day simple moving average broke out above its 200-day moving average; this is known as a “golden cross.”

A golden cross is a technical chart pattern that can signify a potential bullish breakout. It’s formed from a crossover involving a security’s short-term moving average breaking above a longer-term moving average, with the most common moving averages being the 50-day and the 200-day, since bigger time periods tend to form stronger breakouts.

Golden crosses have three key stages that investors look out for. It starts with a downtrend in a stock’s price that eventually bottoms out, followed by the stock’s shorter moving average crossing over its longer moving average and triggering a trend reversal. The final stage is when a stock continues the upward climb to higher prices.

A golden cross contrasts with a death cross, another widely-followed chart pattern that suggests bearish momentum could be on the horizon.

ASRT has rallied 25.6% over the past four weeks, and the company is a #2 (Buy) on the Zacks Rank at the moment. This combination indicates ASRT could be poised for a breakout.

The bullish case only gets stronger once investors take into account ASRT’s positive earnings outlook for the current quarter. There have been 3 upwards revisions compared to none lower over the past 60 days, and the Zacks Consensus Estimate has moved up as well.

Moving Average Chart for ASRT

With a winning combination of earnings estimate revisions and hitting a key technical level, investors should keep their eye on ASRT for more gains in the near future.


Zacks Names “Single Best Pick to Double”

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.


Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.

Click to get this free report


To read this article on Zacks.com click here.


Zacks Investment Research

Health